학술논문
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO
Document Type
Article
Author
Dumas, P.-Y.; Mineur, A.; Pigneux, A.; Raffoux, E.; Dombret, H.; Bérard, E.; Bertoli, S.; Récher, C.; Hospital, M.-A.; Heiblig, M.; Desbrosses, Y.; Bonmati, C.; Pautas, C.; Lambert, J.; Orvain, C.; Banos, A.; Pasquier, F.; Peterlin, P.; Marchand, T.; Uzunov, M.; Frayfer, J.; Turlure, P.; Cluzeau, T.; Jourdan, E.; Himberlin, C.; Tavernier, E.; Villate, A.; Haiat, S.; Chretien, M.-L.; Carre, M.; Chantepie, S.; Vaida, I.; Wemeau, M.; Chebrek, S.; Guillerm, G.; Guièze, R.; Debarri, H.; Gehlkopf, E.; Laribi, K.; Marcais, A.; Santagostino, A.; Béné, M.-C.
Source
In: Leukemia . (Leukemia, January 2023, 37(1):91-101)
Subject
Language
English
ISSN
14765551
08876924
08876924